Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for m acetohexamide to a specific field?

Approximate Matches

2363
Any Name

2349
Standardized Name

1213
Reference Text / Citation

493
Display Name

343
Note

203
Reference URL

132
Related Substance Name

76
Organism Author

62
Relationship Comments

47
Mixture Component Name

30
root_modifications_structuralModifications_molecularFragment_refPname

28
Code Literal

22
Code Comments

17
root_modifications_structuralModifications_residueModified

17
Protein Structural Modification Residue

16
WIKIPEDIA

15
Code URL

9
Structure Stereo Comments

8
ALANWOOD

5
Protein Structural Modification Substance Name

Showing 3831 - 3840 of 4693 results

First page
Previous page
Next page
Next page

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

7D4DLW89CB

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

HLA class I COVID-19 peptide targets

D9QD5G5TPX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

Rebaudioside M 85%

X3YJ76S94Z

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

MATRIX-M1 ADJUVANT

YZ7P8Y8ECX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

AS04

C8385V1KQ6

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

LUCINACTANT

5BSH2G9BH8

Status:

US Previously Marketed

Source:

SURFAXIN by LEES PHARM HK

(2012)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

First approved in 2012

Source:

SURFAXIN by LEES PHARM HK

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

Class:

G1 SPECIFIED SUBSTANCE

SELECTIKINE

EI74F49ZLJ

Status:

Investigational

Source:

NCT00879866: Phase 1 Interventional Completed Lung Cancer

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00879866

Class:

CONCEPT

PD-0360324

EF7PK2TQ0U

Status:

Investigational

Source:

NCT01732211: Phase 2 Interventional Terminated Pulmonary Sarcoidosis

(2013)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01732211

Class:

CONCEPT

IMA-026

P52JII7PAL

Status:

Investigational

Source:

NCT00725582: Phase 1 Interventional Completed Asthma

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00725582

Class:

CONCEPT

AVID-100

91PZ0ZWR8S

Status:

Investigational

Source:

NCT03094169: Phase 1/Phase 2 Interventional Terminated Solid Tumor, Adult

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03094169

Class:

CONCEPT

7D4DLW89CB
Not a public record

Concept

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

D9QD5G5TPX
Not a public record

Concept

HLA class I COVID-19 peptide targets

X3YJ76S94Z
Not a public record

Concept

Rebaudioside M 85%

YZ7P8Y8ECX
Not a public record

Concept

MATRIX-M1 ADJUVANT

Concept

AS04

Concept

LUCINACTANT

Concept

SELECTIKINE

Concept

PD-0360324

Concept

IMA-026

Concept

AVID-100

Showing 3831 - 3840 of 4693 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1